Back to Journals » Biologics: Targets and Therapy » Volume 1 » Issue 1

Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV)

Total article views   HTML views PDF downloads Totals
5,742 Dovepress* 5,742+ 1,732 7,474
Totals 5,742 1,732 7,474
*Since 15 August 2007
+Since July 2016

View citations on Google Scholar